Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2025-12-25 @ 11:24 PM
Study NCT ID:
NCT00126893
Status:
TERMINATED
Last Update Posted:
2007-05-15
First Post:
2005-08-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia
Sponsor:
Celgene Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-09
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-03
First Submit QC Date:
None
Study First Post Date:
2005-08-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-05-14
Last Update Post Date:
2007-05-15
Last Update Post Date Type:
ESTIMATED